[1] Girardi F, Allemani C, Coleman MP. Worldwide trends in survival from common childhood brain tumors:a systematic review[J]. J Glob Oncol, 2019, 5:1-25.
[2] Winston KR. Pediatric neurosurgery:pride and prejudice[J]. Pediatr Neurosurg, 2000, 32:58-68.
[3] Luo SQ, Zhang YQ. Strive to improve the level of pediatric neurosurgery in China[J]. Zhonghua Shen Jing Wai Ke Za Zhi, 2002, 18:345-346.[罗世祺, 张玉琪. 努力提高中国小儿神经外科水平[J]. 中华神经外科杂志, 2002, 18:345-346.]
[4] Alotaibi NM, Noormohamed N, Cote DJ, Alharthi S, Doucette J, Zaidi HA, Mekary RA, Smith TR. Physiologic growth hormone-replacement therapy and craniopharyngioma recurrence in pediatric patients:a meta-analysis[J]. World Neurosurg, 2018, 109:487-496.
[5] Claude L, Faure-Conter C, Frappaz D, Mottolèse C, Carrie C. Radiation therapy in pediatric pineal tumors[J]. Neurochirurgie, 2015, 61:212-215.
[6] Yoo HJ, Kim H, Park HJ, Kim DS, Ra YS, Shin HY. Neurocognitive function and health-related quality of life in pediatric Korean survivors of medulloblastoma[J]. J Korean Med Sci, 2016, 31:1726-1734.
[7] Ingraham FD, Matson DD, Thomas CC. Neurosurgery of Infancy and Childhood[M]. New York:Charles C Thomas, 1954:242-244.
[8] Gjerris F, Klee JG,Klinken L. Malignancy grade and long-term survival in brain tumours of infancy and childhood[J]. Acta Neurol Scand, 1976, 53:61-71.
[9] Johnston DL, Keene D, Kostova M, Lafay-Cousin L, Fryer C, Scheinemann K, Carret AS, Fleming A, Percy V, Afzal S, Wilson B, Bowes L, Zelcer S, Mpofu C, Silva M, Larouche V, Brossard J, Strother D, Bouffet E. Survival of children with medulloblastoma in Canada diagnosed between 1990 and 2009 inclusive[J]. J Neurooncol, 2015, 124:247-253.
[10] Zhang YQ. Ten years development of pediatric neurosurgery in China[J]. Zhonghua Shen Jing Wai Ke Za Zhi, 2012, 28:976-978.[张玉琪. 中国小儿神经外科的十年发展[]J. 中华神经外科杂志, 2012, 28:976-978.]
[11] Karajannis M, Allen JC, Newcomb EW. Treatment of pediatric brain tumors[J]. J Cell Physiol, 2008, 217:584-589.
[12] Mizumoto M, Oshiro Y, Yamamoto T, Kohzuki H, Sakurai H. Proton beam therapy for pediatric brain tumor[J]. Neurol Med Chir (Tokyo), 2017, 57:343-355.
[13] Vinchon M, Baroncini M, Leblond P, Delestret I. Morbidity and tumor-related mortality among adult survivors of pediatric brain tumors:a review[J]. Childs Nerv Syst, 2011, 27:697-704.
[14] MA J. The status of diagnosis and treatment of children's central nervous system tumors in China[J]. Zhonghua Shen Jing Wai Ke Ji Bing Yan Jiu Za Zhi, 2018, 17:193-197.[马杰.我国儿童中枢神经系统肿瘤诊治现状[J]. 中华神经外科疾病研究杂志, 2018, 17:193-197.]
[15] Zheng R, Peng X, Zeng H, Zhang S, Chen T, Wang H, Chen W. Incidence, mortality and survival of childhood cancer in China during 2000-2010 period:a population-based study[J]. Cancer Lett, 2015, 363:176-180.
[16] Smith MA, Altekruse SF, Adamson PC, Reaman GH, Seibel NL. Declining childhood and adolescent cancer mortality[J]. Cancer, 2014, 120:2497-2506.
[17] Park HJ, Moon EK, Yoon JY, Oh CM, Jung KW, Park BK, Shin HY, Won YJ. Incidence and survival of childhood cancer in Korea[J]. Cancer Res Treat, 2016, 48:869-882.
[18] Arora RS, Eden TO, Kapoor G. Epidemiology of childhood cancer in India[J]. Indian J Cancer, 2009, 46:264-273.
[19] Stones DK, De Bruin GP, Esterhuizen TM, Stefan DC. Childhood cancer survival rates in two South African Units[J]. S Afr Med J, 2014, 104:501-504.
[20] Cao KJ, Liu YL, Ma GS. Cancer incidence and mortality of children in urban districts of Guangzhou between 2000 and 2004[J]. Ai Zheng, 2010, 29:359-362.[曹卡加, 刘奕龙, 马国胜. 广州市城区2000-2004年儿童恶性肿瘤发病和死亡率分析[J]. 癌症, 2010, 29:359-362.]
[21] Elliott RE, Hsieh K, Hochm T, Belitskaya-Levy I, Wisoff J, Wisoff JH. Efficacy and safety of radical resection of primary and recurrent craniopharyngiomas in 86 children[J]. J Neurosurg Pediatr, 2010, 5:30-48.
[22] Matsumoto S, Yonai S, Bolch WE. Monte Carlo study of out-of-field exposure in carbonion radiotherapy:organ doses in pediatric brain tumor treatment[J]. Med Phys, 2019, 46:5824-5832.
[23] Raleigh DR, Tomlin B, Buono BD, Roddy E, Sear K, Byer L, Felton E, Banerjee A, Torkildson J, Samuel D, Horn B, Braunstein SE, Haas-Kogan DA, Mueller S. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients[J]. J Neurooncol, 2017, 131:359-368.
[24] James HE, Macgregor TL, Childers DO Jr, La Corte E, Aldana PR. Pediatric neurosurgery patients need more than a neurological surgeon:a clinical experience[J]. Pediatr Neurosurg, 2013, 49:63-68.
[25] Bao Y, Pan J, Qi ST, Lu YT, Peng JX. Origin of craniopharyngiomas:implications for growth pattern, clinical characteristics, and outcomes of tumor recurrence[J]. J Neurosurg, 2016, 125:24-32.
[26] Day EL, Scott RM. The utility of intraoperative MRI during pediatric brain tumor surgery:a single-surgeon case series[J]. J Neurosurg Pediatr, 2019, 23:1-7.
[27] Ginat DT, Swearingen B, Curry W, Cahill D, Madsen J, Schaefer PW. 3 Tesla intraoperative MRI for brain tumor surgery[J]. J Magn Reson Imaging, 2014, 39:1357-1365.
[28] White T, Zavarella S, Jarchin L, Nardi D, Schaffer S, Schulder M. Combined brain mapping and compact intraoperative MRI for brain tumor resection[J]. Stereotact Funct Neurosurg, 2018, 96:172-181.
[29] Stummer W, Stocker S, Wagner S, Stepp H, Fritsch C, Goetz C, Goetz AE, Kiefmann R, Reulen HJ. Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence[J]. Neurosurgery, 1998, 42:518-525.
[30] Cavalli FMG, Remke M, Rampasek L, Peacock J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, Agnihotri S, Thompson YY, Kuzan-Fischer CM, Farooq H, Isaev K, Daniels C, Cho BK, Kim SK, Wang KC, Lee JY, Grajkowska WA, Perek-Polnik M, Vasiljevic A, Faure-Conter C, Jouvet A, Giannini C, Nageswara Rao AA, Li KK, Ng HK, Eberhart CG, Pollack IF, Hamilton RL, Gillespie GY, Olson JM, Leary S, Weiss WA, Lach B, Chambless LB, Thompson RC, Cooper MK, Vibhakar R, Hauser P, van Veelen MC, Kros JM, French PJ, Ra YS, Kumabe T, López-Aguilar E, Zitterbart K, Sterba J, Finocchiaro G, Massimino M, Van Meir EG, Osuka S, Shofuda T, Klekner A, Zollo M, Leonard JR, Rubin JB, Jabado N, Albrecht S, Mora J, Van Meter TE, Jung S, Moore AS, Hallahan AR, Chan JA, Tirapelli DP, Carlotti CG, Fouladi M, Pimentel J, Faria CC, Saad AG, Massimi L, Liau LM, Wheeler H, Nakamura H, Elbabaa SK, Perezpeñ a-Diazconti M, Chico Ponce de León F, Robinson S, Zapotocky M, Lassaletta A, Huang A, Hawkins CE, Tabori U, Bouffet E, Bartels U, Dirks PB, Rutka JT, Bader GD, Reimand J, Goldenberg A, Ramaswamy V, Taylor MD. Intertumoral heterogeneity within medulloblastoma subgroups[J]. Cancer Cell, 2017, 31:737-754.
[31] Kumar R, Liu APY, Northcott PA. Medulloblastoma genomics in the modern molecular era[J]. Brain Pathol, 2019.[Epub ahead of print]
[32] Kokaia Z. Reprogrammed and immune cell for functional regeneration of stroke-damaged brain[DB/OL]. 2019[2019-11-29]. https://2019.febscongress.org/abstract_preview.aspx?idAbstractEnc=4424170094095098096091424170.
[33] Park GK, Kim SH, Kim K, Das P, Kim BG, Kashiwagi S, Choi HS, Hwang NS. Dual-channel fluorescence imaging of hydrogel degradation and tissue regeneration in the brain[J]. Theranostics, 2019, 9:4255-4264.
[34] Doenyas C. Novel personalized dietary treatment for autism based on the gut-immune-endocrine-brain axis[J]. Front Endocrinol (Lausanne), 2019, 10:508.